Tell us what you think about the new Article Page. Send us feedback
LARGO, Fla., Nov. 20 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF - News; TSX Venture Exchange: UVI - News), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the first quarter ended September 30, 2009 (FY2010).
Net sales excluding royalty income, were $1,683,673 in the FY2010 first quarter, 4.4% less then $1,761,526 reported in the previous year first quarter (FY2009). The decrease in sales was primarily a result of less low vision product line sales to our exclusive low vision stocking distributor, offset by a 7.3% increase in sales of our C-Vue brand disposable lenses sold exclusively to licensed eye care practitioners.
Royalty income for the FY2010 first quarter increased 7.6% to a record first quarter of $767,676 compared with $713,397 in the prior-year quarter. Sales of licensed products by our licensee Bausch & Lomb continue to increase, resulting in continued royalty income growth.
FY2010 first quarter income before taxes increased 2.9% to a record first quarter $790,730 compared with $768,259 in the prior-year quarter. After recording net income tax expense of $296,642, Unilens reported net income of $494,088, an increase of 5.9% compared to the previous year quarter , or $0.11 per diluted share. In the FY2009 first quarter, the Company reported net income of $466,367, or $0.10 per diluted share, which included income tax expense of $301,892.
"We are pleased with our first quarter results, considering the current economic environment," stated Michael J. Pecora, Chief Executive Officer of Unilens Vision Inc. "Continued growth for our C-Vue brand of lenses sold exclusively to independent practitioners, combined with a 8% growth in royalty revenue derived from Bausch & Lomb's sales of multifocal lenses that use our key technologies, was responsible for our record performance."
"I am also pleased to report that the Unilens' Board of Directors declared its regular quarterly dividend of US $0.09 per common share, payable next Friday November 27, 2009. "This decision was based on the Company's current balance sheet, and projected operating cash flows and is consistent with the Board's commitment that shareholders should share directly in the earnings achieved by management while continuing to execute our growth strategy," concluded Mr. Pecora.
About Unilens Vision Inc. - "The Independent Eye Care Professionals Contact Lens Company"
Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida, develops, licenses, manufactures, distributes and markets contact lenses primarily under the C-Vue brand directly to Independent Eye Care Professionals. Additional information on the Company may be accessed on the Internet at www.unilens.com. The Company's common stock is listed on the OTC Bulletin Board under the symbol "UVICF" as well as the Canadian TSX Venture Exchange under the symbol "UVI".
(Note: All financial information in this release is stated in U.S. Dollars.)
The information contained in this news release, other than historical information, consists of forward-looking statements that involve risk and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
For more information, please contact:
Leonard F. Barker, CFO, Unilens Vision Inc. at (727) 544-2531
UNILENS VISION INC.
FIRST QUARTER - FISCAL 2010
CONDENSED CONSOLIDATED FINANCIAL INFORMATION
(All figures in U.S. Dollars)
============================
RESULTS OF OPERATIONS
=====================
Three Months Three Months
Ended Ended
September 30, September 30,
2009 2008
------------- -------------
Sales $1,683,673 $1,761,526
Cost of sales 961,371 935,132
------------- ------- -------
722,302 826,394
------- -------
Expenses 703,209 771,961
-------- ------- -------
Income from operations 19,093 54,433
Other items:
Royalty income 767,676 713,397
Other income 468 2,585
Remeasurement income (loss) 535 (4,427)
Interest income 2,958 2,271
--------------- ----- -----
771,637 713,826
------- -------
Income before income tax
expense 790,730 768,259
------------------------ ------- -------
Income tax expense 296,642 301,892
------------------ ------- -------
Net income for the period $494,088 $466,367
========================= ======== ========
Net income per common share:
Basic $0.11 $0.10
Diluted $0.11 $0.10
======= ===== =====
CASH FLOWS
----------
Provided (used) by:
Operating activities $882,127 $706,683
Investing activities (2,926) (32,600)
Financing activities (409,564) (1,774,779)
-------------------- -------- ----------
Increase (decrease) in cash $469,637 $(1,100,696)
====================== ======== ===========
BALANCE SHEET
-------------
September 30, 2009 June 30, 2009
------------------ -------------
Cash and certificates of
deposit $2,148,798 $1,678,626
Total assets 5,787,117 5,749,661
Current liabilities 1,009,244 1,056,312
Total liabilities 1,009,244 1,056,312
Stockholders' equity $4,777,873 $4,693,349
==================== ========== ==========
Copyright © 2010 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.